A novel peptide antagonist of the human growth hormone receptor

Reetobrata Basu, Khairun Nahar, Prateek Kulkarni, Olivia Kerekes, Maya Sattler, Zachary Hall, S.J.C.M.M. Neggers, Justin M. Holub, John J. Kopchick*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
11 Downloads (Pure)


Excess circulating human growth hormone (hGH) in vivo is linked to metabolic and growth disorders such as cancer, diabetes, and acromegaly. Consequently, there is considerable interest in developing antagonists of hGH action. Here, we present the design, synthesis, and characterization of a 16- residue peptide (site 1-binding helix [S1H]) that inhibits hGH-mediated STAT5 phosphorylation in cultured cells. S1H was designed as a direct sequence mimetic of the site 1 minihelix (residues 36-51) of wild-type hGH and acts by inhibiting the interaction of hGH with the human growth hormone receptor (hGHR). In vitro studies indicated that S1H is stable in human serum and can adopt an α-helix in solution. Our results also show that S1H mitigates phosphorylation of STAT5 in cells co-treated with hGH, reducing intracellular STAT5 phosphorylation levels to those observed in untreated controls. Furthermore, S1H was found to attenuate the activity of the hGHR and the human prolactin receptor, suggesting that this peptide acts as an antagonist of both lactogenic and somatotrophic hGH actions. Finally, we used alanine scanning to determine how discrete amino acids within the S1H sequence contribute to its structural organization and biological activity. We observed a strong correlation between helical propensity and inhibitory effect, indicating that S1H-mediated antagonism of the hGHR is largely dependent on the ability for S1H to adopt an α-helix. Taken together, these results show that S1H not only acts as a novel peptide-based antagonist of the hGHR but can also be applied as a chemical tool to study the molecular nature of hGH-hGHR interactions.

Original languageEnglish
Article number100588
JournalJournal of Biological Chemistry
Publication statusPublished - 1 Jan 2021

Bibliographical note

Funding and additional information—This work was supported in part by the State of Ohio’s Eminent Scholar Program to J. J. K. that includes a gift from Milton and Lawrence Goll and by the Edison Biotechnology Institute at Ohio University, Athens, OH. J. M. H. was supported by the Department of Chemistry and Biochemistry and the Edison Biotechnology Institute at Ohio University, Athens, OH.

Publisher Copyright: © 2021 THE AUTHORS.


Dive into the research topics of 'A novel peptide antagonist of the human growth hormone receptor'. Together they form a unique fingerprint.

Cite this